Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: rogermci® who wrote (4931)	7/7/2000 12:37:51 AM
From: WeGotABleeder	Respond to of 6039

Breast Biopsy is the GOLD STANDARD for definitive pathologic diagnosis of breast lesions. Mammography is the diagnostic screening test of choice for most women. Thermal scanning may possibly be an adjunctive screening test but logically why would any highly skilled physician with good judgement use a screening test that is most likely less accurate than the screening tests currently employed. COII has suggested that a thermal scan avoids the discomfort of a mammogram. While a mammogram may be somewhat uncomfortable, the discomfort of a mammogram is substantially less than the mental anguish a patient feels when told they have the diagnosis of breast cancer. Thermal scanning will unlikely avoid the need for breast biopsies as suggested in some of the comments I have read from COII. I would not want to be the physician who tells the patient "you can ignore the lump in your breast, the thermal scan says its likely benign," for that physician will likely become a defendant in a malpractice suit.